Sharh maqola

Treatment modalities for hip and knee osteoarthritis: A systematic review of safety

Osama AweidDepartment of Trauma and Orthopaedics, Luton and Dunstable University Hospital, Luton, Bedfordshire, UKZakir HaiderDepartment of Trauma and Orthopaedics, University College Hospital (London), Fitzrovia, London, UKAbdel SaedDepartment of Trauma and Orthopaedics, Luton and Dunstable University Hospital, Luton, Bedfordshire, UKYegappan KalairajahDepartment of Trauma and Orthopaedics, Luton and Dunstable University Hospital, Luton, Bedfordshire, UK

2018en

ABI

Annotatsiya

Current guidelines on the management of hip and knee osteoarthritis (OA) do not compare safety of treatment modalities. We therefore systematically reviewed 20 studies investigating mortality and serious complications of both medical and surgical treatments for hip and knee OA using PubMed, Scopus, Web of Knowledge and Google Scholar. Mortality was the highest for naproxen (hazard ratio (HR) = 3 (1.9, 4.6)) and lowest for total hip replacement (relative risk (RR) = 0.7 (0.7, 0.7)). Highest gastrointestinal complications were reported for diclofenac (odds ratio (OR) = 4.77 (3.94, 5.76)) and lowest for total knee replacement (HR = 0.6 (0.49, 0.75)). Ibuprofen had the highest renal complications (OR = 2.32 (1.45, 3.71)), whereas celecoxib had the highest cardiovascular risk (OR = 2.26 (1, 5.1)) and lowest was for tramadol (RR = 1.1 (0.87, 1.4)). Results show that medical management of hip and knee OA, particularly with non-steroidal anti-inflammatory drugs, may carry higher mortality compared to surgery. Careful consideration should be given to medical management taking into account known co-morbidities.

Hali tarjima qilinmagan

Identifikatorlar

DOI: 10.1177/2309499018808669

Iqtiboslar va manbalar

2 ta iqtibos0 ta foydalanilgan manba

Koʻrsatkichlar — AkademScholar